CCEL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Cryo-Cell International Inc's research and development for the three months ended in Aug. 2016 was $0.01 Mil. Its research and development for the trailing twelve months (TTM) ended in Aug. 2016 was $0.05 Mil.
This is the expense the company spent on research and development.
Cryo-Cell International Inc Research & Development for the trailing twelve months (TTM) ended in Aug. 2016 was 0.013 (Nov. 2015 ) + 0.009 (Feb. 2016 ) + 0.012 (May. 2016 ) + 0.014 (Aug. 2016 ) = $0.05 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Cryo-Cell International Inc Annual Data
|Research & Development||0.49||0.55||0.19||0.10||0.13||0.18||0.11||0.04||0.06||0.05|
Cryo-Cell International Inc Quarterly Data
|Research & Development||0.02||0.02||0.01||0.01||0.01||0.01||0.01||0.01||0.01||0.01|